Cargando…
Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647232/ https://www.ncbi.nlm.nih.gov/pubmed/36397903 http://dx.doi.org/10.7759/cureus.c78 |
| _version_ | 1784827342530543616 |
|---|---|
| author | Perez, Jesus A Lopez, Javier J Torres Badillo, Claudia C Gill, Jaya Kesari, Santosh Novak, Peter Temnikov, Max Byshovets, Roman Bychkov, Oleg |
| author_facet | Perez, Jesus A Lopez, Javier J Torres Badillo, Claudia C Gill, Jaya Kesari, Santosh Novak, Peter Temnikov, Max Byshovets, Roman Bychkov, Oleg |
| author_sort | Perez, Jesus A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9647232 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Cureus |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96472322022-11-16 Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases Perez, Jesus A Lopez, Javier J Torres Badillo, Claudia C Gill, Jaya Kesari, Santosh Novak, Peter Temnikov, Max Byshovets, Roman Bychkov, Oleg Cureus Correction Cureus 2022-10-14 /pmc/articles/PMC9647232/ /pubmed/36397903 http://dx.doi.org/10.7759/cureus.c78 Text en Copyright © 2022, Perez et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Perez, Jesus A Lopez, Javier J Torres Badillo, Claudia C Gill, Jaya Kesari, Santosh Novak, Peter Temnikov, Max Byshovets, Roman Bychkov, Oleg Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases |
| title | Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases |
| title_full | Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases |
| title_fullStr | Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases |
| title_full_unstemmed | Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases |
| title_short | Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases |
| title_sort | correction: phase 1 first-in-human dose escalation and dose expansion study of kls-1 (64zinc aspartate) in patients with cancer and neurodegenerative diseases |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647232/ https://www.ncbi.nlm.nih.gov/pubmed/36397903 http://dx.doi.org/10.7759/cureus.c78 |
| work_keys_str_mv | AT perezjesusa correctionphase1firstinhumandoseescalationanddoseexpansionstudyofkls164zincaspartateinpatientswithcancerandneurodegenerativediseases AT lopezjavierj correctionphase1firstinhumandoseescalationanddoseexpansionstudyofkls164zincaspartateinpatientswithcancerandneurodegenerativediseases AT torresbadilloclaudiac correctionphase1firstinhumandoseescalationanddoseexpansionstudyofkls164zincaspartateinpatientswithcancerandneurodegenerativediseases AT gilljaya correctionphase1firstinhumandoseescalationanddoseexpansionstudyofkls164zincaspartateinpatientswithcancerandneurodegenerativediseases AT kesarisantosh correctionphase1firstinhumandoseescalationanddoseexpansionstudyofkls164zincaspartateinpatientswithcancerandneurodegenerativediseases AT novakpeter correctionphase1firstinhumandoseescalationanddoseexpansionstudyofkls164zincaspartateinpatientswithcancerandneurodegenerativediseases AT temnikovmax correctionphase1firstinhumandoseescalationanddoseexpansionstudyofkls164zincaspartateinpatientswithcancerandneurodegenerativediseases AT byshovetsroman correctionphase1firstinhumandoseescalationanddoseexpansionstudyofkls164zincaspartateinpatientswithcancerandneurodegenerativediseases AT bychkovoleg correctionphase1firstinhumandoseescalationanddoseexpansionstudyofkls164zincaspartateinpatientswithcancerandneurodegenerativediseases |